Johnson and Johnson accelerates drug development with artificial intelligence

publicat 2026-04-29 00:00:13 (Bursa)

American pharmaceutical giant Johnson and Johnson is increasingly relying on artificial intelligence to significantly reduce the time required to research and develop new treatments, at a time when the pharmaceutical industry is looking for solutions to shorten extremely expensive and time-consuming processes. According to the company and #39;s IT director, Jim Swanson, quoted by Reuters, AI has already managed to halve the time required to identify promising leads for the development of new drugs.

Alte stiri de la Bursa:

SUPLIMENT GAMBLING Pariul riscant al statului pe jocurile de noroc
Eficienta nu vine din utilaje, ci din oameni; Lectia LEAN de la Pehart
ECB: Eurozone banks tighten lending
BCE: Bancile din zona euro au inasprit accestul la creditare
Prognoza meteorologica pentru intervalul 29.04.2026 - 30.04.2026
Berarii Romaniei: Piata berii a coborat la cel mai redus nivel din ultimii 20 de ani
PIATA VALUTARA Euro s-a apreciat la 5,0937 lei
Johnson and Johnson accelereaza dezvoltarea medicamentelor cu ajutorul inteligentei artificiale
BURSELE LUMII Pietele - indecise, in contextul evolutiilor din Iran
TradeVille: Grup EM - crestere pe firul tranzitiei energetice
Romania launches center of excellence in quantum technologies to strengthen cybersecurity
Romania lanseaza un centru de excelenta in tehnologii cuantice pentru consolidarea securitatii cibernetice
Human Rights Watch urges FIFA to secure an 'ICE truce and #8221; for the 2026 World Cup
Human Rights Watch cere FIFA sa obtina un and #8222;armistitiu ICE and #8221; pentru CM 2026
Macro Newsletter 29 Aprilie 2026
EMAG


© Copyright 2000-2026 iStorm. Toate drepturile rezervate.